ADVFN Logo ADVFN

Wir konnten keine Ergebnisse für:
Stelle sicher, dass deine Schreibweise korrekt ist oder versuche deine Suche zu erweitern.

Trends

Toplisten

Es scheint, dass du nicht eingeloggt bist.
Klicke auf den Button unten, um dich einzuloggen und deine zuletzt angesehenen Aktien zu sehen.

Registrieren

Bereits Mitglied? Einloggen

Pepperstone

Jetzt Handeln

Pepperstone
Marktdaten
News
Werkzeuge
Märkte
Entdecken

Hot Features

Follow Feed

Vernetzen Sie sich mit Händlern und Investoren in unserer Follow-Feed-Community.

Optionen-Flow

Erkunden Sie umfassende Optionsdaten und nutzen Sie erweiterte Filter mit Options Flow.

Watchlist

Organisieren und überwachen Sie Ihre Aktien- und Vermögensbeobachtungsliste mit dem Monitor.
Anmelden Premium IconPremium Help Menu
DAX
18.650,55
-0,17%
S&P 500
5.313,64
0,12%
Dow Jones
39.450,82
-0,56%
Euro vs US Dollar
1,08323
0,07%
Bitcoin
67.823,25
-1,85%
Registration Strip Icon for monitor Überwachen Sie mehrere Echtzeitkurse von führenden Börsen wie NASDAQ, NYSE, AMEX, Bovespa und mehr.
Registrieren
  1. Startseite
  2. Investieren
  3. Aktien
  4. USA
  5. USOTC
  6. Pivotal Therapeutics Inc (CE) (PVTTF)

  7. Pivotal Therapeutics Inc (CE) (PVTTF) News

PVTTF

Pivotal Therapeutics (CE) (PVTTF)

Pivotal Therapeutics Inc (CE)
Von:
Sortieren nach:
 Showing the most relevant articles for your search:USOTC:PVTTF
DatumZeitQuelleÜberschriftSymbolFirma
05/05/201423h22MarketwiredCrossover Healthcare Fund Announces Ownership Interest in Pivotal Therapeutics Inc.USOTC:PVTTFPivotal Therapeutics Inc (CE)
07/10/201322h39OTC MarketsPivotal Therapeutics receives CDN $1.65 million in debt financing; Company closes equity portion of financing; over CDN $4.3 ...USOTC:PVTTFPivotal Therapeutics Inc (CE)
07/10/201322h39OTC MarketsPivotal Therapeutics receives CDN $1.65 million in debt financing; Company closes equity portion of financing; over CDN $4.3 ...USOTC:PVTTFPivotal Therapeutics Inc (CE)
02/10/201314h54OTC MarketsPivotal Therapeutics to close equity portion of financing; Enters into $5,000,000 debt financing agreementUSOTC:PVTTFPivotal Therapeutics Inc (CE)
02/10/201314h54OTC MarketsPivotal Therapeutics to close equity portion of financing; Enters into $5,000,000 debt financing agreementUSOTC:PVTTFPivotal Therapeutics Inc (CE)
13/09/201319h49OTC MarketsManagement Discussion and AnalysisUSOTC:PVTTFPivotal Therapeutics Inc (CE)
13/09/201319h46OTC MarketsInterim Financial ReportUSOTC:PVTTFPivotal Therapeutics Inc (CE)
05/09/201318h45OTC MarketsPIVOTAL THERAPEUTICS ANNOUNCES SECOND QUARTER 2013 FINANCIAL RESULTS AND CORPORATE UPDATEUSOTC:PVTTFPivotal Therapeutics Inc (CE)
30/08/201321h24OTC MarketsSupplemental InformationUSOTC:PVTTFPivotal Therapeutics Inc (CE)
30/08/201321h15OTC MarketsSupplemental InformationUSOTC:PVTTFPivotal Therapeutics Inc (CE)
30/08/201321h11OTC MarketsQuarterly ReportUSOTC:PVTTFPivotal Therapeutics Inc (CE)
30/08/201321h06OTC MarketsInterim Financial ReportUSOTC:PVTTFPivotal Therapeutics Inc (CE)
31/05/201306h44OTC MarketsAnnual ReportUSOTC:PVTTFPivotal Therapeutics Inc (CE)
31/05/201306h41OTC MarketsSupplemental InformationUSOTC:PVTTFPivotal Therapeutics Inc (CE)
31/05/201306h33OTC MarketsProxy MaterialsUSOTC:PVTTFPivotal Therapeutics Inc (CE)
31/05/201306h31OTC MarketsProxy MaterialsUSOTC:PVTTFPivotal Therapeutics Inc (CE)
31/05/201306h29OTC MarketsSupplemental InformationUSOTC:PVTTFPivotal Therapeutics Inc (CE)
30/05/201305h51OTC MarketsSupplemental InformationUSOTC:PVTTFPivotal Therapeutics Inc (CE)
30/05/201305h49OTC MarketsSupplemental InformationUSOTC:PVTTFPivotal Therapeutics Inc (CE)
30/05/201305h38OTC MarketsInterim Financial ReportUSOTC:PVTTFPivotal Therapeutics Inc (CE)
30/05/201305h20OTC MarketsQuarterly ReportUSOTC:PVTTFPivotal Therapeutics Inc (CE)
29/05/201318h34OTC MarketsPivotal Therapeutics Announces First Quarter 2013 Financial ResultsUSOTC:PVTTFPivotal Therapeutics Inc (CE)
07/05/201316h55OTC MarketsPivotal Therapeutics VASCAZEN®-REVEAL trial meets primary and secondary endpoints - VASCAZEN® shows 121% correction o...USOTC:PVTTFPivotal Therapeutics Inc (CE)
02/05/201318h07OTC MarketsPivotal's Founder and Chairman Dr. George Jackowski receives Queen Elizabeth II Diamond Jubilee MedalUSOTC:PVTTFPivotal Therapeutics Inc (CE)
01/05/201300h08OTC MarketsPivotal Therapeutics VASCAZEN® - REVEAL Trial Top Line Results to be presented at American Heart Association's Arterioscl...USOTC:PVTTFPivotal Therapeutics Inc (CE)
30/04/201304h08OTC MarketsSupplemental InformationUSOTC:PVTTFPivotal Therapeutics Inc (CE)
30/04/201304h07OTC MarketsSupplemental InformationUSOTC:PVTTFPivotal Therapeutics Inc (CE)
30/04/201304h02OTC MarketsSupplemental InformationUSOTC:PVTTFPivotal Therapeutics Inc (CE)
30/04/201304h00OTC MarketsManagement Discussion and AnalysisUSOTC:PVTTFPivotal Therapeutics Inc (CE)
30/04/201302h38OTC MarketsPivotal Therapeutics Announces 2012 Financial ResultsUSOTC:PVTTFPivotal Therapeutics Inc (CE)
 Showing the most relevant articles for your search:USOTC:PVTTF

Kürzlich von Ihnen besucht

AMEX
SVY.X
BIT
P1VJZ5
NLBNPIT1VJZ5 20240621 25
BITMOT
900725
Efi Sdg Linked Tf 0,875%...
BIT
P1YWA5
NLBNPIT1YWA5 20351221 50...
UNSW3
LOVESNOOPYETH
I LOVE SNOOPY
Delayed Upgrade Clock
ADVFN Logo

Deutschland
Unternehmen
Geschäft
Popular
App herunterladen

Support: +44 (0) 203 8794 460 | support@advfn.de

Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen

© 2024 ADVFN PLC - Alle Rechte vorbehalten